Search is Powered by Google
Liver Disease / Hepatitis News

Children Must Be Protected Against Hepatitis, Warns ABPI

Main Category: Liver Disease / Hepatitis
Article Date: 03 Jul 2008 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

Children should be vaccinated against hepatitis to prevent the spread of medicine-resistant strains of the disease, according to a report published by The Association of The British Pharmaceutical Industry (ABPI).

Strains of Hepatitis B are becoming increasingly resistant to treatment, according to the report, Target Hepatitis, which states that the disease can be prevented through the widespread use of vaccines. Currently no mass vaccination programmes exist in the UK.

"A programme needs to be put into place to ensure that all British children are inoculated against Hepatitis B," said ABPI Medical Director, Dr Richard Tiner. "It is a matter of public health. Much of the rest of Europe operates mass childhood vaccination programmes; it is time that the UK followed suit.

"Hepatitis B is becoming increasingly resistant to antiviral medicines. Once a patient is infected, the disease is difficult to control. We need to focus on the importance of prevention."

According to Target Hepatitis, Hepatitis B - a disease transmitted through bodily fluids - will rapidly become resistant to treatment as mutant forms emerge. In 20 per cent of cases, patients with the condition will find that the disease has mutated within the first year of treatment to the extent that it no longer responds to medicines. Within the first five years of treatment, the number of people who become immune to antiviral medicines rises to 70 per cent.

The UK-based pharmaceutical industry is currently developing many innovative new medicines aimed at controlling resistant strains of the disease, which attacks the liver.

"The UK-based pharmaceutical industry is currently developing a range of new medicines aimed at overcoming antiviral resistance, which will improve the lives of the thousands of patients who are diagnosed with the disease each year," said Dr Tiner.

Notes

Target Hepatitis examines all variants of the disease, including Hepatitis B, Hepatitis C and Hepatitis D and has been produced in association with the British Liver Trust, Hepatitis C Trust and Hepatitis B Foundation UK.

http://www.abpi.org




Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Schizophrenia

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader


Hepatitis C Overview image Hepatitis C Overview

Hepatitis C is called a silent epidemic because many people are unaware they carry this virus of the liver. But experts say hepatitis C is a public health threat on par with HIV...

Hepatitis C Overview image Hepatitis C Overview

Hepatitis C is called a silent epidemic because many people are unaware they carry this virus of the liver. But experts say hepatitis C is a public health threat on par with HIV...

View more videos...